...
首页> 外文期刊>Journal of hypertension >Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes
【24h】

Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes

机译:高血压和2型糖尿病患者的血压状况和糖尿病肾病的发生率

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective:Antihypertensive treatment and blood pressure (BP) reduction are known to retard the progression of diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM) but long-term real-life clinical data on the incidence of DKD are lacking. In this observational, prospective cohort study, we investigated the association between achievement and maintenance of recommended BP values and the incidence of DKD and its components over a 4-year follow-up in patients with T2DM and hypertension from the Italian Medical Diabetologists registry.Methods:Clinical records from a total of 12995 patients with normal renal function and urine albumin excretion at baseline and regular visits during a 4-year follow-up were retrieved and analyzed. The association between recommended, time-updated BP control (BPC) (i.e. 75% of visits with SBP and DBP <140/85mmHg) and the occurrence of renal outcomes was evaluated.Results:At baseline, 28% of patients (n=3612) had recommended BP values. Over the 4-year follow-up, 37% (n=4845) developed DKD, 16% (n=2061) low glomerular filtration rate and 27% (n=3487) albuminuria. Patients who failed to achieve and maintain BPC over the study period showed an increased risk of developing DKD [odds ratio (OR) 1.38, P<0.001], low glomerular filtration rate (OR 1.18, P=0.03) and albuminuria (OR 1.47, P<0.001) as compared with those with persistent BPC. These results were consistent after adjustment for covariates and in different subgroups.Conclusion:Long-term BPC is associated with a reduction in the incidence of DKD and its components in patients with hypertension and T2DM.
机译:目的:已知降压治疗和降低血压(BP)会延迟2型糖尿病(T2DM)的糖尿病肾病(DKD)的进展,但缺乏有关DKD发生率的长期真实临床数据。在这项观察性前瞻性队列研究中,我们调查了意大利医学糖尿病学家注册表中的T2DM和高血压患者,在4年的随访中,建议的BP值的实现和维持与DKD及其成分的发生率之间的相关性。 :检索并分析了总共12995例肾功能正常且基线和定期随访期间尿白蛋白排泄的患者的临床记录,并进行了4年的随访。评价了推荐的,及时更新的BP控制(BPC)(即SBP和DBP <140 / 85mmHg的就诊者的75%)与肾脏预后的发生之间的相关性。结果:基线时,有28%的患者(n = 3612) )具有推荐的BP值。在4年的随访中,有37%(n = 4845)的DKD,16%(n = 2061)的低肾小球滤过率和27%(n = 3487)的蛋白尿。在研究期内未能达到和维持BPC的患者出现DKD的风险增加[比值比(OR)1.38,P <0.001],肾小球滤过率低(OR 1.18,P = 0.03)和白蛋白尿(OR 1.47, P <0.001),与持续性BPC相比。校正协变量和不同亚组后,这些结果是一致的。结论:长期BPC与高血压和T2DM患者的DKD及其成分的发生率降低有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号